Menu
← Oncology Approval Tracker
FDA DECISION ·
Axtle
pemetrexed dipotassium · Avyxa Holdings
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Pemetrexed for selected initial, maintenance and previously treated non-squamous non-small cell lung cancer settings and, with cisplatin, first-line malignant pleural mesothelioma when curative surgery is unsuitable.
LAMPGEN ANALYSIS
Why it matters
This pemetrexed dipotassium presentation adds a product for established lung and mesothelioma settings.
What research teams should watch
Verify labeled salt strength and regimen, and maintain the required folate, vitamin B12 and renal function checks.
PRIMARY RECORDS